Rapid test card is a medical diagnostic test card that qualitatively detects the presence of pathogens in a sample (blood/serum). Rapid test cards are widely used in clinical settings as they offer quick results. Quick tests are utilized as a part of an assortment of purpose of care-settings including homes to essential care centers or emergency rooms.
Some of the common rapid test cards available in the market are Hepatitis test cards, pregnancy test card, HIV test, HCV test, syphilis card/strip test, troponin-I test, and malaria/dengue test cards. Owing to advances in rapid testing technology, today, these tests are widely used in clinics and hospitals.
Rapid test cards usually encompass the interface of an immovable reagent of any of the target antigen or antibody that is associated to certain category of detector which later on reacts with the loaded patient sample. Rapid test cards enable a rapid screening of a possibly affected population, and can be applied for various applications to determine the complications leading for infections or pregnancy.
The development of the rapid test cards market during the forecast period is primarily determined by the expanded usage of rapid test cards mainly in the cases of pregnancy, HIV, malaria, dengue, chikungunya, and leishmanial. Overall growth can be attributed to its low-cost, ease of use, sensitivity, and stability at high temperatures.
Rapid test cards are most favoured for quick and precise outcomes. Rising infection rate from malaria, dengue and other viral infections in developing countries is creating sustained demand for rapid test cards market. The usability of rapid test cards has impelled the appropriation of different test units to differentiate the alteration between various pathogens and other infectious diseases.
However, nonappearance of conclusive diagnostic testing, inaccuracy in readings in few rapid test cards in the domestic market may hamper the overall growth & development of the rapid test card market over the forecast period. Also, few of the high production costs of rapid test cards with high end technology in developing markets may act as a limitation to the overall growth in developing countries.
Globally, the rapid test cards market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan and Middle East and Africa (MEA). North America and Western Europe are predictable to be the principal markets in the global rapid test card market. Multiple diagnostic options among the increasing matured population, are additionally considered vital drivers for this market.
Public awareness via health campaigns by manufacturing and research and development (R&D) companies, government associations, medical campaigns for HIV & malaria and simply available diagnostic tests are relied upon to lift interest for rapid test card procedures in these areas. Asia-Pacific and Latin American region is expected to witness a lucrative growth during the forecast period.
Growth and expansion of rapid test cards in this region can be attributed to the large middle age and young population in this region, growing demand of advanced rapid test cards with quick and accurate results, increasing awareness about new methods of testing and growing health expenditure, especially in India and China.
Rising eruption due to viral infections in this region is aiding market growth during the forecast period. Also, developing economies specifically Brazil and Middle East, offer noteworthy growth opportunities for domestic and international testing card manufacturers due to higher product acceptance and expansion of manufacturers to provide branded products in the international market in lower price with higher security.
Some of the players identified in global Rapid Test Cards market include, Rapid Diagnostics, Right Med Bio System, Avantor Performance Materials, LLC, NanoEnTek Inc., Chr. Hansen Holding A/S, Oscar Medicare Pvt. Ltd, SRI PHARMACARE, Hicks Thermometers Ltd, recombigen laboratories pvt. Ltd., Anbu Pharmaceuticals, V-KEN HEALTH CARE, Safex Health Care, Avantika Medex Pvt. Ltd., Medicare Products Inc. and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types and technology.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Tentatively, global medical penlights market has been segmented on the basis of product type, light output, usage, end user, and geography.
By Test Type
By Distribution Channel
Explore Similar Insights
Rapid Test Cards Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
